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Background: Long-term functional outcome of diaphragm paralysis is largely unknown.
Methods: A retrospective study was conducted in 23 consecutive patients (21 males,
5679 years) with uni- or bilateral diaphragm paralysis to examine whether functional
respiratory recovery can be predicted from the compound motor action potential (CMAP)
of the diaphragm at the time of diagnosis. Pulmonary function and CMAP were evaluated at
baseline and at follow-up. CMAP amplitude and latency were recorded by surface
electromyography with percutaneous electrical stimulation of the phrenic nerve. Patients
were followed for (median) 15 months up to 131 months (range 5–131). Functional
respiratory recovery was defined as an increase in forced vital capacity 4400ml.
Results: Functional recovery occurred in 43% of the patients after 12 months (10 out of
23) and in 52% after 24 months (12 out of 23). Type and etiology of paralysis did not
influence recovery. CMAP, anthropometric characteristics and baseline pulmonary function
did not predict functional respiratory recovery. Whether respiratory muscle training
improved pulmonary function is uncertain. Moreover, it did not result in a greater
percentage functional respiratory recovery. Relapse after an initial improvement was
observed in 26% of the patients.
Conclusions: The present study indicates that functional recovery of diaphragm paralysis
is difficult to predict and may occur years after the onset of the paralysis.
& 2008 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Diaphragm paralysis recovery 691Introduction
Interruption of the integrity of the phrenic nerve results in
dysfunction of the ipsilateral hemidiaphragm, whereas
bilateral diaphragm paralysis or paresis requires either
lesion of both phrenic nerves or of the central nervous
system. Typical causes of uni- and bilateral diaphragm
paralysis or paresis include neuromuscular diseases1,2 or
isolated phrenic nerve conduction abnormality due to
trauma, and inadvertent interruption of the phrenic nerve
during surgical procedures in the neck3 or thorax.4 In most
cases of diaphragm paralysis, the etiology remains unknown
and paralysis is unilateral.5–7
Nerve conduction study of the phrenic nerve is useful in
diagnosing a neuromuscular disease involving the dia-
phragm. Indeed, the compound motor action potential
(CMAP) of the diaphragm is often reduced in amplitude
in patients with diaphragm weakness compared with
healthy subjects.8,9 If the phrenic nerve lesion is complete,
no diaphragm action potential is obtained after phrenic
nerve stimulation.4 Because the function of the diaphragm
is dependent on phrenic nerve integrity, it can be speculated
that severe or complete phrenic nerve damage may be
associated with a poor prognosis for recovery. Hence, a
phrenic nerve conduction study performed at the onset of
symptoms may be a predictor of diaphragm functional
recovery (FR). Indeed, in contrast to imaging techniques
and ultrasound, it assesses the functionality of the dia-
phragm. In contrast to fluoroscopy, it can be used in any
environment including the intensive care unit. Similarly,
magnetic stimulation was not used in the present study
because this technique was not available in our department
as a routine technique 11 years ago. Still today, electrical
nerve stimulation is more widely available in clinical
routine. Further, this technique is still not used in
our center to stimulate the phrenic nerves especially in
an ICU environment where magnetic field may interfere
with proper function of monitoring equipment used for
the patient. Finally, because electrical stimulation is a
widely used technique implemented in most hospitals
as a routine technique, we speculated that it could
have been a promising tool for prognosis of recovery
from diaphragm paralysis. Importantly, in the present
study, this technique was used during the whole
duration of the study and the same investigator performed
the test.
On the other hand, since vital capacity (and related
forced vital capacity (FVC)) is influenced by the ability of all
inspiratory muscles to generate a change in volume,
measurements of vital capacity may be a useful tool to
follow functional respiratory recovery in patients with
diaphragm paralysis. This simple and accessible parameter
is, indeed, used as a standard in clinical practice, especially
because the fall in vital capacity from upright to supine
position may be used to delineate respiratory from other
pathology. As such, patients with diaphragmatic paralysis
show substantial fall in vital capacity on lying down10 and
this has been advocated as a clinical test for diaphragm
weakness.11 Thus, in the context of absence of concomitant
pulmonary disease, any improvement in vital capacity may
be attributed to an improvement in respiratory muscle
function. In the present study, vital capacity values wereused as a simple tool to follow functional respiratory
recovery in patients with diaphragm paralysis.
The prognosis for recovery from diaphragm paralysis is
difficult to determine. The available studies are mostly case
reports or include small numbers of patient (generally
o15).7,12–19 Follow-up of the patients is generally shorter
than 4 years.12–14,16–19 Recovery (usually detected by
diaphragm CMAP, ultrasound, fluoroscopy, chest X-ray or
transdiaphragmatic pressure) may occur months after onset
of the paralysis12,13,16–19 while in other cases, phrenic nerve
injury appears irreversible.14 The time course of recovery of
the phrenic nerve is also depending on the type of injury and
the distance over which regeneration occurs.19 Because
clinicians need better prediction of long-term functional
respiratory recovery after uni- and bilateral diaphragm
paralysis to base their clinical decision making on regarding
treatment options and to inform patients on the anticipated
outcome of their disease, we retrospectively analyzed all
patients referred to our center in the past 11 years. The aim
was to evaluate recovery rate of uni- and bilateral paralysis
and to determine whether functional respiratory recovery
based on FVC measurements could be predicted by different
variables including a phrenic nerve conduction study and
pulmonary function.
Methods
Population
The 23 patients (21 males; mean age, 5679 years; height,
17378 cm; body mass index, 2875 kgm2) included in this
study were referred to the pulmonary outpatient clinic of
our university hospital between August 1994 and June 2005
for dyspnea. The referral source was chest physicians for 14
patients and general practitioners for the remaining nine
patients. The patients included in the present study were in
fact patients referred to our center for whom an electro-
myographic examination was asked by the consulted chest
physician (MD). The diagnosis of unilateral (left side: n ¼ 5;
right side: n ¼ 11) or bilateral (n ¼ 7) diaphragm paralysis
was confirmed after clinical and functional examination
(pulmonary function, diaphragm electromyography or chest
radiography). Seven patients came to the clinic within 1
week after the onset of their complaint, eight came
between 2 and 4 months and seven came more than 5
months after the probable onset of the disease, while no
information was available for one patient. The ethics
committee of the University Hospitals Leuven granted
approval for this retrospective study.
Design
Baseline phrenic nerve conduction studies were performed
within 2 days after baseline pulmonary function tests.
Patients were subsequently followed up at the discretion
of the treating chest physician or until June 2005. Functional
respiratory recovery was defined as an improvement in FVC
(DFVC) greater than 400ml. This value was chosen as more
than twice the FVC reproducibility error range (150ml).20 If
patients recovered, the FVC at the time of recovery was
used as the recovery follow-up measure and patients were
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G. Gayan-Ramirez et al.692included in the FR group. If patients did not recover, they
were included in the non-functional recovery (NFR) group
and the last available FVC was chosen as the follow-up
assessment. At recovery follow-up time, maximal mouth
pressures were measured in 19 patients and phrenic nerve
conduction in six patients. During follow-up, 21 patients
performed inspiratory resistive muscle training. Training
modalities were adapted for each patient and consisted of a
daily 30min session of resistive breathing performed against
an inspiratory resistance (40% of maximal inspiratory
pressure, PI max).
Pulmonary function tests
Spirometry (Sensor Medics 6200, Bilthoven, The Nether-
lands) was performed in the sitting position21 in all patients
and also in the supine position in most patients (n ¼ 15). The
best forced expiratory volume in 1 s (FEV1) and FVC of at
least three reproducible efforts for each position were
expressed as a percentage of the predicted values.21 Total
lung capacity (TLC) and functional residual capacity (FRC)
were also assessed according to the ERS guidelines for
pulmonary function testing.19
Maximal expiratory mouth pressure (PEmax) was measured
at TLC and PI max at residual volume according to the
modified method of Black and Hyatt.22 For this purpose, a
rigid tube with a standardized leak was placed against the
mouth to measure inspiratory and expiratory pressures using
an electronic pressure transducer. Both maximal mouth
pressures were determined as pressures that could be
sustained for at least 1 s. Maximal verbal encouragement
was given. Tests were repeated until variability among the
three best attempts was less than 5%. The best value was
reported and expressed as percentage of the predicted
value.23
Phrenic nerve study
Phrenic nerve conduction was measured according to the
technique described by Bolton’s group.8 Each phrenic nerve
was stimulated sequentially at the posterior border of the
sternocleidomastoid muscle in the supraclavicular fossa,
just above the clavicle. A square-wave electrical pulse of
0.1ms was delivered by a handheld felt-tipped bipolar
stimulating electrode, connected to an electromyographic
system (Medelec Synergy, Surrey, United Kingdom). After
locating the phrenic nerve, stimulus intensity was increased
until the maximal CMAP amplitude was obtained. Electrical
phrenic nerve stimulation was further increased by another
20% to ensure supramaximality. The CMAP was recorded
bipolarly with two surface electrodes (silver cup electrodes
filled with conductive paste and taped to the skin). As
described by Bolton,24 the active electrode was located 5 cm
above the tip of the xiphoid process and the reference
electrode was placed 16 cm from the active electrode at the
costal margin (level of the seventh intercostal space). A
ground electrode was placed on the manubrium sterni. For
each patient, stimulations were repeated until three
reproducible CMAPs were obtained except when the CMAP
was of low amplitude (100 mV or less), then five reproducible
CMAPs were collected. CMAP amplitude and latency weremeasured using standard procedure. For CMAP latency,
conduction time was measured from the stimulus artefact to
the beginning of the (negative) deflection of the CMAP
signal. For statistical analysis, CMAP values in patients with
unilateral diaphragm paralysis were the values recorded on
the affected side, whereas in patients with bilateral
diaphragm paralysis the mean CMAP value of both sides
was taken. An abnormal diaphragmatic response was defined
as a CMAP amplitude below 300 mV and a CMAP latency
higher than 8.1ms which is in the range of previously
reported limit.8
Statistical analysis
The differences between two groups of patients (uni- vs.
bilateral, or FR vs. functionally non-recovery) were assessed
with unpaired Student’s t-test or Mann–Whitney U-test
according to data distribution. Differences between the
three etiologic groups (idiopathic, neurologic, etc.) were
assessed with a one-way ANOVA test (followed by LSD Fisher
post-hoc test) or Kruskal–Wallis ANOVA test. However,
caution is needed when interpreting data of these subgroups
because there were only two patients in the neurologic
group. Within each group, differences were analysed by a
paired Student’s t-test or Wilcoxon test. Pearson’s correla-
tions and multiple regression analyses were performed for
the whole group of patients between DFVC and (1) anthro-
pometric and spirometric parameters, (2) CMAP values,
(3) DPI max, DPEmax and (4) recovery duration. Proportions
were compared with a Fisher test. Statistics were performed
with Statistica 6.1 (Statsoft France, Maisons-Alfort, France).
Significance was set at po0.05. Data were expressed as
mean7SD.
Results
Baseline data
Clinical data
Seven patients had bilateral paralysis and 16 unilateral
paralyses. For 61% of the patients, the etiology of the
diaphragm paralysis was unknown or uncertain (idiopathic
group). For the others, the diaphragm paralysis was the
consequence of trauma (Nos. 12, 19), sequel of surgery
(Nos. 4, 9 and 20), neurologic disease such as diabetic
polyneuropathy and Laurence–Moon–Bieds (Nos. 15, 23),
paraneoplasy (No. 7) or partial diaphragm resection because
of a tumor (No. 8).
Pulmonary function
TLC and FRC were 5.271.7 l (76719% predicted) and
3.171.1 l (89729% predicted), respectively. As expected,
patients with unilateral paralysis had significantly better
baseline pulmonary function than patients with bilateral
paralysis (Table 1). However, baseline FVC was lower than
the expected value for unilateral paralysis (75% predicted)
in seven patients but yielded normal values in three patients
(Figure 1). As previously reported,11 the changes in FVC from
sitting to supine position were greater in patients with
bilateral than unilateral paralysis (48714 vs. 28714%,
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Table 1 Baseline clinical characteristics of patients with diaphragm paralysis.
Patient Baseline
FVC (%pred) FEV1 (%pred) PI max (%pred) CMAP
Amplitude (mV) Latency (ms)
Left Right Left Right
Bilateral
1 45 40 14 80 150 11 11
2 54 49 63 NR NR NR NR
3 43 43 21 40 70 12 11
4 65 50 77 100 63 12 13
5 58 53 25 40 41 9.9 10
6 60 52 29 NR NR NR NR
7 45 50 29 136 37 12 20
Mean7SD 5379 4875 37724
Unilateral
8 97 84 74 NR 600 NR 8
9 126 104 79 120 480 14.2 7.8
10 47 46 23 NR 90 NR 9.8
11 49 49 9 14 100 9.9 7.7
12 60 46 68 NR 70 NR 9.3
13 98 96 93 620 NR 7.6 NR
14 83 64 55 200 100 7.6 10.7
15 72 67 72 90 40 12.8 26.8
16 71 61 79 400 55 7.9 10.8
17 72 70 72 500 NR 8.1 NR
18 76 63 66 280 NR 10.8 NR
19 48 50 73 290 NR 7.4 NR
20 53 46 36 120 NR 8.1 NR
21 48 45 73 450 NR 8.1 NR
22 87 67 47 120 85 8.5 8.2
23 54 52 57 500 NR 6 NR
Mean7SD 71723 63718 61722
FVC ¼ forced vital capacity; FEV1 ¼ forced expiratory volume in 1s; PI max ¼ maximal inspiratory mouth pressure; CMAP ¼ diaphragm
compound muscle action potential; %pred ¼ percentage of predicted normal value, NR ¼ no electromyographic response to phrenic
nerve stimulation.
po0.05 vs. bilateral.
Diaphragm paralysis recovery 693po0.01). No differences in baseline pulmonary function
were observed between the groups with different etiology.Respiratory muscle function
As expected, PI max was lower in patients with bilateral
paralysis than in patients with unilateral paralysis (Table 1).
Nevertheless, PI max was lower than expected in five
patients with unilateral paralysis (Figure 1). In two of them,
PI max yielded values normally obtained with bilateral
paralysis. On the other hand, PI max reached values higher
than expected in three patients with unilateral paralysis
although FVC was lower than expected. Maximal expiratory
pressure was normal and did not differ between the group
with unilateral (95727% predicted) and bilateral (90734%
predicted) paralysis. No differences in baseline mouth
pressures were observed between the groups with different
etiology.Phrenic nerve study
Diaphragm paralysis was confirmed by absence of a CMAP in
12 patients or by an abnormal CMAP in 11 patients (Table 1).
Patient No. 15 with diabetic polyneuropathy in whom a
CMAP was obtained had a longer baseline phrenic nerve
conduction time than patients with idiopathic etiology
(1071.1ms, n ¼ 7) or other etiology namely sequel of
surgery and paraneoplasy (1472ms, n ¼ 3). Baseline CMAP
was not influenced by whether diaphragmatic paralysis was
uni- or bilateral.Data obtained at follow-up
Pulmonary function
Pulmonary function of patients was followed-up for a
median of 15 months (5–131 months). Patients had 674
spirometries during follow-up. FVC improvement greater
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Figure 2 Evolution of functional respiratory recovery for a
24-month follow-up. Data are expressed as a percentage of
total amounts of patients (A) and as number of patients (B).
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Figure 1 Individual data of forced vital capacity (FVC) and
maximal inspiratory pressure (PI max) at baseline in patients with
unilateral (open circles) or bilateral (close circles) diaphragm
paralysis. Dotted lines represent the expected value of FVC and
PI max for patients with unilateral diaphragm paralysis. Dashed
lines represent the expected value of FVC and PI max for patients
with bilateral diaphragm paralysis. FVC and PI max are expressed
as percentage of the predicted values.
G. Gayan-Ramirez et al.694than 400ml was seen in 35% of the patients after 6 months
(eight patients out of 23), in 43% after 1 year (10 out of 23)
and in 52% after 2 years (12 out of 23) (Figure 2). Patient
anthropometric characteristics did not change significantly
over time (except for age). Functional respiratory recovery
occurred in 50% and in 71% of the patients with unilateral or
bilateral paralysis, respectively (w2 ¼ 0.9, p ¼ 0.3). Half of
the patients with either an idiopathic (n ¼ 714) or another
etiology (n ¼ 47) and the two patients with a neurologic
disease recovered. FVC improved beyond 400ml in one of
the three patients with unilateral paralysis and normal
baseline FVC. Baseline data were similar in the FR and NFR
groups (Table 2). By definition, the FR group had a greater
improvement in pulmonary function than the NFR group
(Table 3).
In 10 patients, FVC decreased either after an initial
increase beyond 400ml (named relapse for the FR group,
n ¼ 5) or compared with baseline (NFR group, n ¼ 5). In the
FR group, the etiology of relapse was unknown (three
patients), or was due to respiratory muscle training
cessation (one patient), or progressing type 2 diabetes
mellitus neuropathy (one patient). In the NFR group, FVC
decrease coincided with training cessation (three patients),
an associated event (two patients). Pulmonary function
improvement was not different according to type of
paralysis (uni- or bilateral) or etiology.Respiratory muscle function
Changes in PI max tended to be larger in the FR group
(p ¼ 0.1) while the PEmax remained unchanged over time.
Improvement in PI max was related to improvement in FVC
(r ¼ 0.7, po0.001).
Respiratory muscle training was started within 1 month
after the baseline FVC measurement in 20 patients (0.872
months) and after 45 months in one patient. Two patients
did not participate to this training. Training lasted 22724
months. PI max (DPI max, 17715% predicted, po0.001) and
FVC (DFVC, 1957330ml, 578% predicted, po0.01) were
significantly increased at the end of training independently
of disease etiology and type of paralysis (uni- or bilateral).
Within the FR group, one patient did not train, one
recovered before starting training while the 11 other
patients recovered 979 months after training. In the FR
group, PI max increased significantly by 20717% predicted
(po0.001) and FVC by 979% predicted (3437363ml,
po0.05). In the NFR group, the increase in PI max (12713%
predicted, po0.05) did not result in functional respiratory
recovery. In patients with unilateral paralysis, recovery did
not necessarily occur with training.Phrenic nerve study
Phrenic nerve conduction was reassessed at follow-up in six
patients. In four patients with a CMAP response at baseline
(Table 1), three still displayed abnormal CMAP at follow-up
but two of them showed FR (Table 2). The last patient had a
quasi-normal value at follow-up and recovered (Table 4). For
the remaining two patients with a CMAP response at
baseline, CMAP amplitude and latency did not improve at
follow-up while both patients showed FR of the FVC. The
fact that patients had uni- or bilateral diaphragm paralysis
did not influence CMAP evolution. These data showed that
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Table 2 Baseline characteristics of functional respiratory recovery and non-functional respiratory recovery groups.
Functional recovery group (n ¼ 13) Non-functional recovery group
(n ¼ 10)
Unilateral/bilateral paralysis 8/5 8/2
FVC L (%pred) 2.671 (62716) 3.0571.6 (70726)
FEV1 L (%pred) 1.970.6 (55712) 2.271.1 (63721)
PI max %pred 50721 58730
PEmax %pred 95725 92733
No CMAP value n ¼ 8 n ¼ 4
CMAP
Latency (ms) 1477 (n ¼ 5) 1272 (n ¼ 6)
Amplitude (mV) 73733 (n ¼ 5) 71741 (n ¼ 6)
Same abbreviations as in Table 1. PEmax ¼ maximal expiratory mouth pressure. Values are expressed as mean7SD.
Table 3 Pulmonary function and maximal mouth
pressures between baseline and follow-up measurements
for functional respiratory recovery and non-functional
recovery groups.
Functional
recovery group
(n ¼ 13)
Non-functional
recovery group
(n ¼ 10)
Recovery follow-
up duration
(months)
778 25720*
DFVC L 0.670.2y 0.170.5y
DFVC %pred 135y 2711y
DFEV1 L 0.370.3
y 0.170.5*
DFEV1 %pred 9.577.5
y 2.3712*
DPI max %pred 16716 (n ¼ 12)z 1721 (n ¼ 7)#
DPEmax %pred 2714 (n ¼ 12) 5714 (n ¼ 6)
Same abbreviations as in Table 2; D ¼ difference between
baseline and follow-up measurements. Values are expressed
as mean7SD. Difference between groups. *po0.01;
ypo0.001; #p ¼ 0.1. Difference compared with baseline:
zpo0.01; ypo0.001.
Diaphragm paralysis recovery 695functional respiratory recovery was not necessarily asso-
ciated with normalization of the CMAP values.
Sensitivity of the nerve conduction study to detect
functional diaphragm recovery in the whole group was low
(36%, confidence interval 12–68%). Specificity was 32%
(confidence interval 11–64%). None of the baseline char-
acteristics (anthropometric characteristics, baseline pul-
monary function, baseline CMAP) were predictive of
functional respiratory recovery.Discussion
The present study describes functional respiratory recovery
in patients diagnosed with uni- or bilateral diaphragm
paralysis. The study showed that functional consequences
of uni- or bilateral diaphragm paralysis are partially
reversed in 43% of patients after 1 year, but improvement
was not predictable from baseline measurements such as
pulmonary function or phrenic nerve conduction para-meters. Type of paralysis (uni- or bilateral) and disease
etiology did not influence functional respiratory recovery.
Inspiratory muscle training is feasible but whether respira-
tory muscle training was associated with pulmonary function
improvement remains uncertain.
In the present study, patients were not actively recruited.
Only the patients referred to our center for whom an
electromyographic examination was asked by the consulted
chest physician were included. In addition, patients with
disease known to deteriorate (e.g. spinal ALS) were not
included, as recovery is not expected in this population. In
the past 11 years, 23 patients were diagnosed with
diaphragm paralysis in our hospital, demonstrating the low
incidence of this pathology. It may be possible that the
incidence of this pathology was underestimated since only
the patients referred to our center or those developing the
problem in our university hospital were included in the
present study. But, on the other hand, these cases may also
represent the most complex ones while in the primary or
secondary center diagnosis might have been associated with
spontaneous recovery not necessitating further investiga-
tion. In the present study, most cases were unilateral as
previously reported.5–7 Diaphragm paralysis in our patients
was long standing with recovery extended to more patients
when follow-up was longer. Average time from diagnosis to
FR (6 months for 35% of the patients, 1 year for 43% of the
patients and 2 years for 52% of the patients) is similar to that
previously described by Wilcox et al.19 Type of diaphragm
paralysis (uni- or bilateral) and its etiology did not
significantly influence FR or CMAP value at recovery. Delay
of recovery was not linked to severity of baseline phrenic
nerve alteration. Moreover, the absence or presence of
electromyographic response to phrenic nerve stimulation at
baseline was not indicative of CMAP improvement. This
study may have been too small or conducted in a too
heterogeneous group of patients to exclude the role of
electromyography in predicting prognosis. However, in
clinical practice, clinicians will always have to deal with
small and heterogeneous groups.
Retrospective studies have inherent limitations. As with
any long-term retrospective study, not all the patients
performed all the tests at each hospital visit (maximal
respiratory muscle force, phrenic nerve conduction study)
and they were not evaluated at regular time intervals
although all visits were supervised by the same treating
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Table 4 Clinical characteristics of patients with diaphragm paralysis at recovery follow-up. Same abbreviations as in Tables 1
and 2; time ¼ time elapsed between ‘‘recovery’’ follow-up and baseline data measurement.
Patient Recovery follow-up
DFVC (ml) DPI max
(%pred)
Time
(months)
CMAP Follow-up total
duration
(months)Amplitude (mV) Latency (ms)
Left Right Left Right
Bilateral
1* 490 6 7 – – – – 131
2* 460 12 11 NR 80 NR 13.7 11
3 30 5 7 – – – – 7
4 260 20 11 160 100 10.5 10.3 19
5* 560 0 2 – – – – 23
6* 630 7 30 160 60 10.9 16.2 43
7* 510 28 14 – – – – 105
8* 680 21 4 – – – – 37
9 240 9 9 130 380 14.6 7.7 9
10 360 – 27 – – – – 39
Unilateral
11 360 – 68 – – – – 104
12* 430 4 4 – – – – 15
13 270 4 9 600 30 7.3 10 13
14 110 – 15 – – – – 15
15* 520 1 1 – – – – 5
16 1280 36 45 – – – – 65
17 80 11 34 – – – – 34
18* 440 7 10 700 500 11.6 10.2 21
19 230 – 29 – – – – 29
20* 1130 16 2 – – – – 69
21* 440 46 1 – – – – 12
21* 600 42 17 – – – – 20
23* 490 12 – – – – 62
*Recovered patient,  no data available.
G. Gayan-Ramirez et al.696physician (MD). However, the aim of this analysis was to
characterize potential for recovery after diaphragm paraly-
sis and to investigate whether any measurement performed
at baseline would be predictive of favorable outcome. We
feel that the present retrospective study serves this aim as
all consecutive patients with diaphragm paralysis followed
in our center between 1994 and 2005 have been included in
the analysis. To our knowledge, the follow-up duration is one
of the longest (up to 131 months) and the patient group one
of the largest studied to date.7,12,13,15–19
In the present study, functional impairment was assessed
using spirometry. This technique has been shown to be
reproducible in sick and elderly subjects and is easily
applied in clinical routine.20,25,26 Intra-session reproduci-
bility of FVC is generally reported to be within 120–150ml20
and intersession reproducibility to be less than 6% of
baseline FVC.25,26 Hence, an increase in FVC beyond
400ml as used in the present study clearly represents more
than the expected error range and should indicate physio-
logical and probably clinically relevant improvement. In our
study, impairment of patients with unilateral and bilateral
diaphragm paralysis was well within the expected range for
baseline FVC,3,15,27 FEV1,
27 PI max and PEmax.
28 The fact thatsome patients with unilateral diaphragm paralysis had
baseline FVC within normal limits has already been reported
previously.19 Decrease in FVC in supine position was also
comparable to that reported by Davis et al.1
Besides, FVC appeared to be normalized earlier than
CMAP value. Since FVC reflects global inspiratory muscle
function and CMAP is representative of the diaphragm only,
normalization of FVC earlier than CMAP is conceivable. It
remains speculative whether this recovery is enhanced by
inspiratory muscle training as no control group was studied.
FVC improvement was less than PI max improvement and not
high enough to result in functional respiratory recovery.
Interestingly, it should be noted that 10 patients showed
relapse or decreased FVC compared with baseline measure-
ment. For three patients of the NFR group, worsening of FVC
occurred while respiratory muscle training was stopped.
However, the beneficial effect of respiratory muscle training
is difficult to determine in the present study since no control
group was studied.
This study alerts clinicians that a potential relapse
after an initial improvement may occur in a relatively
large portion (26%) of the patients. This has never been
reported previously, and surely merits further attention.
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Diaphragm paralysis recovery 697Unfortunately, neither baseline pulmonary function, nor
baseline respiratory muscle function were predictive of
functional respiratory recovery.
Another technique used in the present study to assess
functional impairment was the phrenic nerve conduction
study. Although today several techniques such as motion and
imaging techniques are available to analyze diaphragm
function, CMAP measurement in response to phrenic nerve
stimulation is a well-established technique to characterize
phrenic nerve dysfunction8 and proved to be a helpful tool in
differential diagnosis of diaphragm paralysis.29 Methodolo-
gical weaknesses of electrical stimulation technique have
been previously described24,30 such that only the major
difficulties will be addressed here. The most significant
disadvantage reported with electrical stimulation is dis-
comfort caused by the intensity stimulus. Although this may
be painful, it remains, however, relatively well tolerated by
the patients. In subconscious and sedated patients, this
technique is routinely applied without major difficulties.
Locating the phrenic nerve may require some practice but is
feasible for an expert performing this test routinely.
Actually, location of both phrenic nerves in all subjects
tested is not a limiting factor as previously reported by
several groups.8,9,30,31 Attention should also be paid to
potential co-stimulation of the plexus brachial during
stimulation of the phrenic nerve. This may contaminate
the CMAP signal. This co-stimulation is obvious when the arm
is moving during the stimulation. In addition, this co-
stimulation will result in an initial positive deflection on
the CMAP signal. Adjustment of the electrode position is
necessary to rule out the plexus brachial signal. CMAP signal
may also be affected by the ECG signal. Actually, the
morphology of the ECG signal is very similar to that of the
CMAP. But ECG artefact occurs randomly while CMAP is time
locked to the stimulus, at such they can be distinguished
from each other. Another important issue with electrical
stimulation is the absence of response. This may be true but
this may represent a technical problem to record CMAP
(false negative response). In that case, consecutive trials
while adjusting location of the electrode (stimulating and
pick-up electrodes) as well as stimulus pulse and strength
need to be performed to ensure the validity of no response.
In the present study, the above-mentioned points were
taken into account to ensure reliability of the measure-
ments. Our data show that phrenic nerve conduction time at
baseline was prolonged on the affected side, consistent with
phrenic nerve dysfunction. In addition, low PI max and normal
PEmax values were consistent with isolated diaphragm
paralysis rather than generalized respiratory muscle weak-
ness. However, baseline phrenic nerve conduction studies
were not predictive of functional respiratory recovery.
Perhaps, functional respiratory recovery may be predicted
by techniques other than phrenic nerve stimulation. Lisboa
et al.15 highlighted that in patients with unilateral dia-
phragm paralysis other respiratory muscles became active
during quiet breathing to compensate for the impaired
diaphragmatic function.
In conclusion, the present study showed that functional
respiratory recovery occurred in 43% of the patients 1 year
after diaphragm paralysis diagnosis and in 52% of the
patients after 2 years. Type or etiology of the paralysis did
not influence functional respiratory recovery. Respiratorymuscle training may help to improve pulmonary function
independently of paralysis type and disease etiology.
Unfortunately, functional respiratory recovery could not be
predicted from routine assessment performed in regular
clinical work-up. However, the present study may help
clinicians to inform patients about prognosis of isolated uni-
or bilateral diaphragm paralysis. It shows that FR of
diaphragm paralysis may occur late after the onset of
paralysis.
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